Aardvark Share Price
NASDAQ: AARD | Micro Cap | HealthcareAardvark Stock Performance
Aardvark Share Price Today
As of 19 November 2026, Aardvark Therapeutics, Inc.'s share price is $1.01. The stock opened at $1.12, compared to its previous close of $1.18. During today's trading session, Aardvark Therapeutics, Inc.'s share price traded between $1.01 and $1.12, with an average price of $1.06. Over the past 52 weeks, the stock has recorded a high of $16.41 and a low of $0.94. In terms of performance, Aardvark Therapeutics, Inc.'s share price has declined by 75.30% over the last six months and is down 89.81% on a year-on-year basis.
Aardvark Share Price Chart
Aardvark Quarterly Profit & Loss
All figures in USD
Aardvark Annual Profit & Loss
All figures in USD
Aardvark Balance Sheet
All figures in USD Million
Aardvark Cash Flow
All figures in USD Million
About Aardvark
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Aardvark Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.36 | $1.01 | -26.28% |
Oct 2026 | $5.23 | $1.37 | -74.08% |
Sep 2026 | $6.22 | $5.29 | -20.53% |
Aug 2026 | $6.74 | $6.65 | +2.62% |
Jul 2026 | $5.76 | $6.48 | +12.60% |
Jun 2026 | $3.98 | $5.75 | +40.02% |
May 2026 | $5.17 | $4.11 | -24.10% |
Apr 2026 | $3.87 | $5.42 | +44.40% |
Mar 2026 | $5.72 | $3.75 | -70.20% |
Feb 2026 | $12.80 | $12.59 | -2.97% |
Jan 2026 | $12.60 | $12.97 | -0.92% |
Dec 2025 | $9.95 | $13.09 | +31.43% |